Clinical Trial Update: Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma

View source ↗

Summary

A completed clinical trial in oral squamous cell carcinoma uses MRI radiomics of intratumoral and peritumoral habitats to predict pathologic complete response t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Squamous Cell Carcinoma

Snippet

Sponsor: Zilong Yuan | Conditions: Pathologic Complete Response | Status: COMPLETED